Wang, K., Ding, J., Li, X., Guo, W., Zhu, X., Su, Y., . . . Ding, L. (2022). Effects of itraconazole and rifampicin on the pharmacokinetics and safety of youkenafil, a novel phosphodiesterase type 5 inhibitor, in healthy Chinese subjects. European journal of pharmaceutical sciences, 175, 106213. https://doi.org/10.1016/j.ejps.2022.106213
Chicago-Zitierstil (17. Ausg.)Wang, Keli, Juefang Ding, Xianjing Li, Wenjing Guo, Xingyu Zhu, Yue Su, Luning Sun, Huan Zhou, und Li Ding. "Effects of Itraconazole and Rifampicin on the Pharmacokinetics and Safety of Youkenafil, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Chinese Subjects." European Journal of Pharmaceutical Sciences 175 (2022): 106213. https://doi.org/10.1016/j.ejps.2022.106213.
MLA-Zitierstil (9. Ausg.)Wang, Keli, et al. "Effects of Itraconazole and Rifampicin on the Pharmacokinetics and Safety of Youkenafil, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy Chinese Subjects." European Journal of Pharmaceutical Sciences, vol. 175, 2022, p. 106213, https://doi.org/10.1016/j.ejps.2022.106213.